"Florida Eye Associates is Brevard County's recognized leader in ophthalmology, providing families and seniors with quality eye care since 1967. Our board-certified team of ophthalmologists and optometrists provide comprehensive care from routine eye services to cataract and retinal surgery, LASIK surgery, and services for patients with low vision. We also offer a hearing center, a state of the art surgery center ASC of Brevard, and four convenient office locations in Melbourne, Cocoa Beach, Viera, and Palm Bay."

During the past decade, Florida Eye Associates conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 12 clinical trials were completed, i.e. on average, 38.7% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 8 clinical trials were completed. i.e. 47.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Florida Eye Associates" #1 sponsor was "Hoffmann-La Roche" with 16 trials, followed by "Kodiak Sciences Inc" with 5 trials sponsored, "Genentech, Inc." with 4 trials sponsored, "4D Molecular Therapeutics" with 1 trials sponsored and "AffaMed Therapeutics (US) Inc." with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Florida Eye Associates" #1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator and "Regeneron Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Florida Eye Associates" are "Geographic Atrophy" (9 trials), "Diabetic Macular Edema" (5 trials), "Macular Edema" (3 trials), "Neovascular Age-Related Macular Degeneration" (3 trials) and "Macular Degeneration" (2 trials). Many other conditions were trialed in "Florida Eye Associates" in a lesser frequency.

Most popular intervention types in "Florida Eye Associates" are "Drug" (29 trials), "Other" (13 trials), "Procedure" (4 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (13 trials), "Faricimab" (9 trials), "Aflibercept" (8 trials), "KSI-301" (5 trials) and "Lampalizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Florida Eye Associates" are 33 trials for "All" genders.

Currently, there are NaN active trials in "Florida Eye Associates". undefined are not yet recruiting, 5 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Florida Eye Associates, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Florida Eye Associates, 4 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".